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Background: This study aims to determine the prognostic accuracy of term MRI in very preterm born (≤32 weeks)
or low-birth-weight (≤1500 g) infants for long-term (>18 months) developmental outcomes.
Methods: We performed a systematic review searching Central, Medline, Embase, and PsycInfo. Two independent
reviewers performed study selection, data extraction, and quality assessment. We documented sensitivity and
specificity for three different MRI findings (white matter abnormalities (WMA), brain abnormality (BA), and diffuse
excessive high signal intensity (DEHSI)), related to developmental outcomes including cerebral palsy (CP), visual
and/or hearing problems, motor, neurocognitive, and behavioral function. Using bivariate meta-analysis, we
estimated pooled sensitivity and specificity and plotted summary receiver operating characteristic (sROC) curves for
different cut-offs of MRI.
Results: We included 20 papers published between 2000 and 2013. Quality of included studies varied. Pooled
sensitivity and specificity values (95 % confidence interval (CI)) for prediction of CP combining the three different MRI
findings (using normal/mild vs. moderate/severe cut-off) were 77 % (53 to 91 %) and 79 % (51 to 93 %), respectively.
For prediction of motor function, the values were 72 % (52 to 86 %) and 62 % (29 to 87 %), respectively. Prognostic
accuracy for visual and/or hearing problems, neurocognitive, and/or behavioral function was poor. sROC curves of the
individual MRI findings showed that presence of WMA provided the best prognostic accuracy whereas DEHSI did not
show any potential prognostic accuracy.
Conclusions: This study shows that presence of moderate/severe WMA on MRI around term equivalent age can
predict CP and motor function in very preterm or low-birth-weight infants with moderate sensitivity and specificity.
Its ability to predict other long-term outcomes such as neurocognitive and behavioral impairments is limited.
Also, other white matter related tests as BA and DEHSI demonstrated limited prognostic value.
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Preterm birth is associated with an increased risk of
neurodevelopmental problems [1]. Magnetic resonance
imaging (MRI) is increasingly being used to identify
cerebral white matter lesions in the brain of preterm
infants at term equivalent age. It is claimed to be a
valuable tool to predict neurodevelopmental outcomes
in very preterm infants, and its clinical use is, therefore,
being promoted [2, 3]. However, the prognostic accuracy
of white matter related MRI abnormalities for long-term
developmental outcomes is debatable and its use as a
standard of care is not yet recommended by the
American Academy of Neurology Quality Standards [4].
The lack of meta-analytic synthesis of the primary stud-
ies reporting prognostic values, which tends to show
conflicting results, hampers the debate.
Subsequently, the lack of knowledge about the prog-
nostic accuracy of term MRI hampers an adequate inter-
pretation of this test. This may invoke unwanted effects,
as parents may worry unnecessarily about the possible
abnormal development of their child [5, 6]. However, if
term MRI can predict neurodevelopmental outcomes ac-
curately, the use of this expensive diagnostic procedure
as part of standard care could be justified as it may
select high risk infants for prolonged and intensive
supportive care.
Our study aims to evaluate the following two questions:
1. What is the prognostic accuracy (in terms of sensi-
tivity and specificity) of white matter related abnormal-
ities seen on term MRI for long-term developmental
outcomes of infants born very preterm or with low birth
weight?
2. Is there a difference in prognostic accuracy between
the three types of white matter abnormalities as seen on
term MRI including white matter abnormality, a
combination of cerebral white matter lesions defined as
“brain abnormality,” and diffuse excessive high signal
intensity? To answer these questions, we performed a
systematic review and meta-analysis on the subject.
Methods
We performed a systematic review following the guidance
of the PRISMA statement, Cochrane Handbook for
Systematic Reviews of Diagnostic Test Accuracy and other
recommendations found in the literature [7–9], with a




We searched Central, Medline, Embase, and PsycInfo
from their inception to November 2013 for relevant
studies. The search was performed by a trained clinical
librarian (AL) and two other authors (TdH and JvH).Broad text and MeSH terms were used. Also, keywords
of eligible papers were screened and included in the final
search. We did not apply any language restrictions. The
search was limited to studies including humans. The full
search in all these databases can be seen in Additional
file 1. References from included studies were checked.
Abstracts and reports from meetings were included only
if they related directly to previously published work.
Eligibility criteria
The following inclusion criteria were used to select stud-
ies: (1) the study pertained to infants born at a gesta-
tional age ≤ 32 weeks and/or birth weight ≤ 1500 g; (2)
MRI should be planned at term equivalent age (37–42
weeks) with a maximum range of 3 weeks earlier or later
(34–45 weeks); (3) MRI findings should be related to
any developmental outcome; and (4) developmental
follow-up should be performed ≥18 months postnatal
age. Isolated single case studies and review articles were
not included.
Abstracts were screened for eligibility by two inde-
pendent reviewers (JvH and TdH). Full-text articles were
retrieved if applicable to the core research question, or if
the abstract did not supply sufficient information. Any
disagreement was set by discussion until consensus. The
same two reviewers appraised the methodological quality
and performed the data extraction. Any disagreement at
this stage was resolved by a third reviewer.
Methodological quality
Due to lack of existing quality assessment tools for prog-
nostic accuracy studies, we developed a modified version
of the QUADAS-2 assessment tool [10] to evaluate the
risk of bias (see Additional file 2).
Data extraction
A standardized data extraction form (see Additional file
3) was used to record study information. The results of
white matter abnormalities (WMA) and brain abnormal-
ities (BA) are usually expressed as either no, mild, mod-
erate, or severe abnormalities as described by Inder and
Woodward et al. [11, 12]. Where possible we defined
two cut-offs, i.e., (1) no abnormality vs. mild, moderate,
or severe abnormality, reported as “normal vs. any” and
(2) no or mild abnormality vs. moderate to severe abnor-
mality, reported as ‘normal/mild vs. moderate/severe’.
BA was defined as a combination of WMA plus pres-
ence of other brain abnormalities such as ventricular
hemorrhage or increased ventricle size. For diffuse ex-
cessive high signal intensity (DEHSI), the results are
usually expressed as either present or absent. Therefore,
only one cut-off was used in the 2 × 2 tables presenting
the results for these MRI findings.
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was defined as a minus 2 standard deviations (−2SD) differ-
ence from the mean for each MRI finding. If this cut-off
was not reported (but for example, only a −1.25 or −1SD),
we used the reported cut-off in the meta-analysis.
In cases of duplicate reporting, i.e., the same cohort
was described in two papers or one paper reporting de-
velopmental outcomes at different time points of age, we
used data from the paper that reported the developmen-
tal outcome at a comparable age with the other included
papers. For example: if two papers reported motor skills
at 2 years of age and one paper reported at 2 and 6 years
of age, the reporting at 2 years of age was used. In case
two papers reported the same cohort at similar ages, the
study with the largest sample size and least quality
concerns was selected. If the required data could not be
extracted from the publication, authors were contacted by
email. All data were entered in Review Manager (RevMan)
version 5.3. Copenhagen: The Nordic Cochrane Centre,
The Cochrane Collaboration, 2012.Statistical analysis
We performed a meta-analysis using a bivariate modeling
approach [13]. In view of the observed heterogeneity, a
random-effects model was used. We compared pooled
sensitivity and specificity (95 % confidence intervals); likeli-
hood ratios of positive and negative test results (LR+/LR−)
were calculated from the pooled sensitivity and specificity;
diagnostic odds ratios (DOR), and posttest probabilities of
three different MRI findings (WMA, BA and DEHSI), for
all types of developmental outcomes. Sensitivity and speci-
ficity for individual studies and summary receiver operating
characteristic curves (sROC) were plotted to visualize pos-
sible heterogeneity of data and overall test accuracy.Results
Our search strategy yielded 1311 citations after removal
of duplicates (Fig. 1). A total of 44 papers met the inclu-
sion criteria, of which 27 papers provided 2 × 2 tables.
One more relevant paper was identified by contact with
the authors. After excluding multiple publications from
the same cohorts (8 papers), a total of 20 papers were
available for the meta-analysis.
The 20 papers were all published between 2000 and
2013. These papers reported on 12 different cohort stud-
ies (2 retrospective and 10 prospective) including 1287
patients (682 male and 605 female). The extracted data
provided 54 2 × 2 tables for WMA, BA, or DEHSI. These
three MRI findings were used for the prediction of vari-
ous developmental outcomes: cerebral palsy (CP), visual
and/or hearing problems, motor, neurocognitive, and
behavioral function, as well as a combination of prob-
lems in these domains defined as ‘neurodevelopmentalimpairment’ (NDI). Study characteristics are shown in
Additional file 4: Table S1.
Studies from which 2 × 2 tables could not be derived
(n = 17 papers, not reported in this manuscript) reported
continuous data with no cut-offs. These studies mostly
reported the following MRI tests: cerebellar abnormal-
ities, volumes, and diameter measures of the brain (total
brain or specific regions as hippocampus, corpus callo-
sum, or ventricles).Methodological quality of included studies
In general, 70 to 90 % of the included studies scored
positive on each of the QUADAS-2 quality assessment
items (Fig. 2). For example, 90 % of the studies included
in the meta-analysis used a consecutive sample of very
preterm born and/or low-birth-weight neonates over a
specific period of time in their clinic (Fig. 2). In general,
a good description of the MRI test and reference stand-
ard was provided, as well as a verification process to all
neonates who had a MRI performed. However, almost
50 % of the papers did not report blinding of the test re-
sults, i.e., results of the MRI findings are not (made)
available to the person performing the follow-up neuro-
developmental test.Meta-analysis
The reported sensitivity and specificity were generally
higher for the WMA tests when compared to BA or
DEHSI findings (Table 1). Fig. 3 shows the sROC curves
for prediction of four different developmental delays re-
lated to any MRI abnormality (combination of WMA,
BA, or DEHSI tests) using a ‘normal/mild vs. moderate/
severe’ cut-off. The sROC curve for prediction of CP
shows a curve that lies the most towards the (optimal)
upper left corner of the ROC space. Also the sROC
curve for prediction of motor function has a tendency to
the upper left corner. The sROC curves for mental im-
pairment and neurodevelopmental impairment, which
are visualized in Fig. 3, are heading more towards the
diagonal (non-discriminating) line of the ROC space.
The pooled sensitivity and specificity values (95 % con-
fidence interval (CI)) for prediction of CP were 77 % (53
to 91 %) and 79 % (51 to 93 %), respectively. Almost
similar values were found for the prediction of motor
function with a sensitivity of 72 % (52 to 86 %) and spe-
cificity of 62 % (29 to 87 %). Lower values were found
for mental development and NDI with sensitivity of
66 % (41 to 84 %) and 53 % (35 to 71 %), respectively,
and specificity of 61 % (34 to 83 %) and 85 % (75 to
92 %). Using a “normal vs. any” cut-off, pooled sensitivity
and specificity values were 84 % (45 to 97 %) and 58 %
(27 to 84 %) for prediction of CP; 76 % (48 to 92 %) and
26 % (8 to 57 %) for prediction of motor function; and
1311 records identified through
database search after removal of
duplicates
2 record identified through other
sources
1313 records screened
83 full-text articles assessed for eligibility
1230 records excluded
39 full-text articles excluded, with
reasons:
N=3 no relation between MRI and
follow up
N=4 follow up too short
N=3 MRI <34 and >45 weeks
N=9 MRI >45 weeks
N=7 included preterms >32 weeks
N=1 cohort of <10 patients
N=12 abstracts of conferences with
no full text available
44 studies included in qualitative
synthesis
20 studies included in quantitative
synthesis (meta-analysis including 59
2x2 tables)
17 studies did not provide 2x2 tables
8 studies published double data
1 study with two 2x2 tables included
after contact with authors
Fig. 1 Flowchart of study selection
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of mental development, respectively.
Figure 4 shows the sROC curves corresponding to the
two different cut-offs: “normal vs. any” and “normal/
mild vs. moderate/severe” when only the results of
WMA are taken into consideration for prediction of
various developmental outcomes. If only moderate to se-
vere WMA lesions are coded as abnormal (“normal/mild
vs. moderate/severe”), the specificity increases and the
sensitivity decreases.
The spread of the individual studies alongside the
sROC curves in Figs. 3 and 4 shows a substantial hetero-
geneity of the collected data explained by a threshold
effect. The threshold effect is similar to the shift in
sensitivity and specificity as described above, yet without
an explicit change in cut-off levels. The shift is presum-
ably the result of an implicit use of a different threshold,
e.g., following from subjective judgments or calibration
of diagnostic devices.
Discussion
This study shows that the presence of moderate/severe
WMA on MRI performed around term equivalent age
can predict CP and motor function in very preterm or
low-birth-weight neonates with moderate sensitivity and
specificity. The ability to predict other long-termoutcomes such as neurocognitive and behavioral impair-
ments is limited. Also, other white matter related tests
as BA and DEHSI demonstrated limited to no prognos-
tic value.
In the last decade, the use of MRI as a screening tool
for very preterm and low-birth-weight neonates has
been a topic of major interest and several reviews have
been published on its use [3, 14–18]. Most of these re-
views are narrative (describing practical issues like sed-
ation for MRI and/or different types of MRI techniques)
or examined the impact of preterm birth and brain ab-
normalities on long-term development through the use
of MRI. Although none of them systematically reported
test accuracy of MRI for prediction of developmental
outcome, most of these reviews, however, recommended
the use of term MRI in clinical practice. To our best
knowledge, our study is the first that systematically re-
views the prognostic accuracy of different MRI findings
on various long-term developmental outcomes.
Clinical implications
The data in our meta-analysis suggest that presence of
moderate/severe WMA has higher positive likelihood ra-
tio, and absence of any WMA has a higher negative like-
lihood ratio than any other tests that we now use for
preterm infants (e.g., cranial ultrasound or neurological
Fig. 2 Quality assessment of included studies in meta-analysis (n = 20)
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finding on MRI therefore supports the use of MRI for pre-
term infants. However, whether this alters clinical manage-
ment is a different question. Answering this question was
beyond the scope of our meta-analysis. In our opinion
however, showing potential prognostic accuracy of a test
does not directly justify its clinical use as a standard test.
The usefulness of this tool for clinical decision-making
requires the presence of possible treatment or specified
follow-up strategies following the results of the MRI [20].
At present, there is no specific treatment available ad-
dressing the needs of infants with abnormal white matter
on MRI. However, the use of term MRI results may give
focus to specific follow-up programs (i.e., offering a
screening tool for developmental disorders at an earlier
age) or improve selection of neonates for early interven-
tion programs (i.e., physiotherapy or speech therapy).
Also, available MRI results may help parents of prema-
turely born infants to better prepare for the future.
On the other hand, after screening all very preterm born
or low-birth-weight neonates with a term MRI, there is no
other tests available with better accuracy. Therefore, the
possible harm due to false positive and false negative re-
sults must be taken into consideration. The value of being
timely informed (value of information) must be weighted
against the possibility of unnecessary concern for adverse
outcome [21, 22]. For example, based on the results of thismeta-analysis, we can expect that the finding of moderate
to severe WMA in a very preterm born child will increase
the probability of developing CP from the known preva-
lence of 7 % in this population to 37 % (Table 1). This
raises the question if this increase in probability will
change practice for both the clinician and patient. More
specifically, will the clinician offer a different follow-up
program when the risk of developing CP is 37 % instead of
7 %? And will the negative posttest probability of 2.5 %
(i.e., 2.5 % will still develop CP after a normal MRI test
result) justify a denial of follow-up to those with normal
MRI?
Our meta-analysis also shows that adverse outcomes,
such as neurocognitive and behavioral impairments,
could not be predicted by term MRI abnormalities.
Compromised white matter may result in more “subtle”
impairments in such areas of the child’s long-term func-
tion. The limited prognostic value of WMA for these
specific outcomes also suggests that despite MRI abnor-
malities, whether or not a child develops neurocognitive
and behavioral impairments, is also dependent on other
factors. Such other factors may include the presence of a
stimulating home and/or school environment, educa-
tional level of the parents, and therapy use [23, 24].
Other considerations relevant to deciding on the use of
MRI for the prediction of developmental outcomes are the
substantial health care costs associated with its use. In
Table 1 Results from bivariate analysis on sensitivity (Sens), specificity (Spec), 95 % confidence interval (95 % CI), diagnostic odds





















CP 1 [35] 125 100
(70–100)
81 (73–87) >100 5.27 <0.01 7.2 29.0 <0.01
IQ 2 [36, 37] 283 79 (65–88) 41 (18–69) 2.61 1.34 0.51 16.6 21.1 9.2
Language 2 [37, 38] 283 87 (69–97) 30 (23–39) 2.78 1.24 0.44 5.3 6.5 2.4
Mental development 3 [12, 35, 39] 448 81 (59–93) 49 (26–73) 4.13 1.60 0.39 13.8 20.4 5.9
Motor 3 [12, 35, 40] 485 87 (74–94) 51 (26–76) 7.29 1.80 0.25 17.3 27.4 5.0




CP 2 [41, 42] 164 67 (38–87) 92 (85–96) 22.35 8.11 0.36 6.7 36.8 2.5
IQ 2 [36, 37] 283 53 (39–67) 83 (77–87) 5.41 3.06 0.57 16.6 37.9 10.2
Language 2 [37, 38] 283 47 (24–71) 86 (82–90) 5.46 3.38 0.62 5.3 15.9 3.4
Mental development 3 [12, 39, 41] 398 38 (26–52) 87 (83–91) 4.21 2.98 0.71 13.8 32.3 10.2
Working memory 2 [43, 44] 258 24 (17–32) 88 (78–94) 2.26 1.96 0.87 47.7 64.1 44.2
Motor 3 [12, 40, 41] 435 54 (30–77) 90 (84–94) 10.59 5.37 0.51 17.5 53.2 9.7
NDI 1 [12] 167 38 (26–53) 86 (78–91) 5.28 2.70 0.72 28.1 51.4 22.0
BA—“normal vs. any” CP 2 [36, 45] 277 90 (68–98) 60 (54–66) 13.71 2.27 0.17 7.2 15.0 1.3
Mental development 1 [46] 180 100 (61–100) 60 (52–67) >100 2.49 0.00 3.3 7.5 <0.01
Behavior 1 [47] 177 76 (61–88) 37 (29–46) 1.88 1.21 0.64 23.7 27.3 16.6
Hearing 2 [36, 46] 397 100
(51–100a)
58 (53–63) >100 2.49 0.00 2.0 4.9 <0.01
NDI 2 [36, 46] 424 81 (69–89) 68 (61–75) 9.44 2.57 0.27 13.9 29.3 4.2
BA—“normal/mild
vs. moderate/severe”
CP 3 [46, 48, 49] 273 90 (74–97) 80 (75–85) 37.83 4.56 0.12 11.4 36.9 0.02
Mental development 2 [46, 50] 216 82 (8–100) 75 (69–81) 13.80 3.31 0.24 8.3 23.1 0.02
Hearing 2 [36, 46] 397 100
(51–100a)
75 (70–79) >100 3.97 <0.01 2.0 7.5 <0.01
Motor 1 [50] 34 63 (31–86) 73
(54–86a)
4.53 2.32 0.51 23.5 41.7 13.6
Behavior 1 [47] 177 33 (20–50) 78 (70–84) 1.75 1.50 0.86 23.7 31.8 21.1
NDI 3 [36, 51, 52] 405 60 (39–78) 86 (70–94) 8.96 4.17 0.47 28.2 54.0 11.7
DEHSI CP 2 [41, 45] 421 46 (9–89) 39 (3–92) 0.55 0.76 1.38 6.2 4.8 8.3
Mental development 3 [35, 41, 53] 362 87 (72–94) 19 (9–35) 1.53 1.07 0.70 10.5 11.1 7.6
Motor 3 [35, 41, 53] 362 86 (70–94) 20 (8–40) 1.48 1.07 0.72 10.5 11.1 7.8
If bivariate model could not estimate 95 % CI for pooled sensitivity for two studies, estimate is based on study with largest sample size
BA brain abnormality, DEHSI diffuse excessive high signal intensity, NDI neurodevelopmental impairment, WMA white matter abnormality
adata derived after contact with author
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use is severely restricted. Also, expert neuroradiologists
are needed for proper interpretation of the MRI results. In
view of its potential prognostic capacity, it is therefore still
debatable whether performing a standard term MRI is
cost-effective.
Limitations
This meta-analysis has some limitations that need to be
considered. Although a considerable number of studieswere identified on the subject, only a limited number of
data points were available for each specific combination
of MRI findings and neonatal outcome. Although even
the results of only two studies can be pooled, the limited
number of data points and often limited sample size per
study imply limited power (hence wide confidence
intervals) [25].
Also, the presence of heterogeneity may raise the
question whether pooling of results is justified in our
study. In prognostic meta-analysis, two possible reasons
a. Cerebral palsy b. Motor function
c. Mental impairment d. neurodevelopmental impairment 
(NDI)
Fig. 3 Pooled sensitivity and specificity with sROC reporting four developmental outcomes detected by any MRI abnormality (including white
matter abnormality, brain abnormality or diffuse excessive high signal intensity using ‘normal/mild vs. moderate/severe’ cut-off). a (n = seven
studies): pooled sensitivity 77 % (53 to 91 %) and specificity 79 % (51 to 93 %). b (n = seven studies): pooled sensitivity 72 % (52 to 86 %) and
specificity 62 % (29 to 87 %). c (n = seven studies): pooled sensitivity 66 % (41 to 84 %) and specificity 53 % (35 to 71 %). d (n = four studies):
pooled sensitivity 61 % (34 to 83 %) and specificity 85 % (75 to 92 %). The individual studies are visualized as squares with the horizontal axis
corresponding to the total non-diseased neonates and vertical axis the total diseased neonates of that particular study population, i.e., a flat square
represents a low prevalence of the disease, and the surface of the square represents the size of the study population
van’t Hooft et al. Systematic Reviews  (2015) 4:71 Page 7 of 10for heterogeneity of the data are known i.e., clinical het-
erogeneity, due to differences in features of the cohorts,
and heterogeneity due to threshold effect. We estimate a
smaller impact of the clinical heterogeneity as all cohorts
included consecutive and comparable populations (al-
though inadequate and inconsistent reporting of possible
confounders in the studies, e.g., use of medication, birth
weight, and presence of neonatal complications during
admission, made it impossible to correct for potential
confounders in our meta-analysis). Heterogeneity due tothreshold effect is a common occurrence in many diag-
nostic test systematic reviews and probably explaining
most of the heterogeneity in our meta-analysis [9]. The
threshold effect in MRI tests is explained by the relative
subjectivity of interpretations of MRI results e.g., one
lesion on the MRI might be seen as abnormal for one
radiologist but not by another. Also the use of different
scoring systems and differences in background of the
evaluators (neonatologists or radiologist) contribute to
this type of heterogeneity. For this review, heterogeneity
a. Developmental delay in case of ‘normal vs. any’ WMA (n=13 studies)
b. Developmental delay in case of ‘normal/mild vs. moderate/severe WMA 
(n=15 studies)
Fig. 4 Pooled sensitivity and specificity with sROC corresponding to two different cut-offs of WMA for prediction of for various developmental
outcomes/delays (cerebral palsy, IQ, working memory, visual and/or hearing, mental development, language and motor function delay). a
Developmental delay in case of “normal vs. any” WMA (n = 13 studies). b Developmental delay in case of “normal/mild vs. moderate/severe” WMA
(n = 15 studies). The line represents the sROC curve. The black dot represents the pooled sensitivity and specificity. The blank squares represents
the individual studies, with the horizontal axis corresponding to the total non-diseased and vertical axis the total diseased of that particular
study population
van’t Hooft et al. Systematic Reviews  (2015) 4:71 Page 8 of 10due to different scoring systems is probably the case in
studies describing “brain abnormalities.” These studies
not only include WMA as one of the MRI findings but
also a composite of other MRI findings (i.e., IVH and/or
increased ventricle size). However, since this heteroge-
neous definition of “brain abnormality” reflects common
practice, we included these diverging MRI findings.Furthermore, the quality of the included studies varied.
In general, the majority of the studies were of good qual-
ity, although the lack of reporting of blinding of the MRI
test at follow-up assessment in almost 50 % of the pa-
pers is a point of concern. However, in view of the
limited number of included studies, subgroup analyses
by excluding low quality studies is unlikely to resolve
van’t Hooft et al. Systematic Reviews  (2015) 4:71 Page 9 of 10this question, as it would merely lead to broader confi-
dence intervals [26]. As with all reviews, this systematic
review is susceptible to publication bias. Especially co-
hort studies that did not show any predictive value of
MRI have a lower chance of being published. The effect
of publication bias may have resulted to overestimation
of the predictive value of MRI in our meta-analysis.Recommendations for clinical care and further research
There is a solid evidence that very preterm birth and
low birth weight has negative consequences on motor,
neurocognitive, and behavioral functioning [1, 27, 28].
Preterm birth is also associated with variable degrees of
brain injury and reduced brain volumes [18, 29]. A
multitude of possible confounding factors play a role in
the developmental outcomes of these fragile infants. Al-
though MRI results can add valuable information on the
prediction of long-term development, this information is
in our opinion too marginal to use it on its own. A next
step to consider is the performance of an individual pa-
tient data (IPD) analysis gathering the results from the
individual level. First, this will enhance correction of
confounders of the different cohort studies. Second, this
extensive data-analyses technique may be used to de-
velop a prognostic model, in which the presence of
WMA on MRI can be combined with other biomarkers
known to influence long-term development such as gen-
der, neonatal history, clinical symptoms as infection [30],
poor nutrition [31], use of steroids [32], low birth
weight, socio-demographic factors, other imaging tech-
niques as ultrasonography [33], or other promising MRI
techniques that might show moderate prognostic accur-
acy in the near future (e.g., MR spectroscopy, diffusion
tensor imaging (DTI), and neurite orientation dispersion
and density imaging (NODDI)) [34]. A model statisti-
cally combining various relevant prognostic factors likely
increases the accuracy to predict outcomes and may
therefore be a more valuable tool for clinical use than
MRI on its own.Conclusions
This meta-analysis shows that the presence of moderate/
severe WMA on MRI around term equivalent age can
predict CP and motor function in very preterm or low-
birth-weight neonates with moderate sensitivity and spe-
cificity. The ability to predict other long-term outcomes
such as neurocognitive and behavioral impairments is
limited. Before considering the use of this test as a
standard test in clinical practice, we encourage the con-
tinued use of routine MRI in a research setting to gener-
ate further evidence on its prognostic capacity together
with other prognostic factors.Additional files
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